Retrospective study to assess the safety and efficacy of Vedolizumab in patients with Inflammatory Bowel Disease in a real-world setting
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 06 Jan 2017 New trial record